Allergan Ltd

Marlow International, The Parkway, Marlow, Bucks, SL7 1YL, UK
Telephone: +44 (0)1628 494444
Fax: +44 (0)1628 494449
WWW: http://www.allergan.co.uk
Medical Information Direct Line: +44 (0)1628 494026
Medical Information e-mail: UK_MedInfo@Allergan.com
Out of Hours contact: +44 (0)1628 494026

Summary of Product Characteristics last updated on the eMC: 06/09/2007
SPC Ocufen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/09/2007 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   11/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

 

7

Marketing authorization holder

Text updated

Address updated to new Marlow address

10

Date of revision of text

Text updated

24th November 2006 replaces 17th May 2005

Updated on 29/09/2005 and displayed until 06/09/2007
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 23/10/2003 and displayed until 29/09/2005
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/08/2001 and displayed until 23/10/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 28/06/2001 and displayed until 20/08/2001
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   flurbiprofen